Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

In contrast to other diseases (including SS, LSS, MCTD, Behçet’s disease, UCTD, Takayasu arteritis, and SSc), SLE was associated with increased OR of lung invovlment [11.667, 95% CI 1.940,70.178, P = 0.007].Factors associated with lung involvement in rheumatic diseasesVariablesUnivariate model 1Multivariate model 1Multivariate model 2OR95% CIP-valueOR95% CIP-valueOR95% CIP-valueAge0.9510.751 to 1.2050.6790.8120.598 to 1.1040.1830.8310.581 to 1.1880.309Sex(female)3.4921.012 to 12.0510.048*5.7020.993 to 32.7450.0516.9140.967 to 49.4200.054Type of disease SLE11.6671.940 to 70.1780.007*24.1922.305 to 253.9600.008* JIA2.9170.594 to 14.3270.1877.0790.400 to 125.2280.182 JDM6.6670.597 to 74.5060.1236.1060.338-110.3140.220 OthersRefRef ESR1.0261.001 to 1.0520.039*1.0371.003 to 1.0720.032* CD4/CD85.6251.145 to 27.6380.033*9.8751.296 to 75.2430.027*6.7780.770 to 59.6410.085*P < 0.05 was considered statistically significantAbbreviations: OR Odds ratio, CI Confidence interval, SLE Systemic lupus erythematosus, JIA Juvenile idiopathic arthritis, JDM Juvenile dermatomyositis, CRP C-reactive protein, ESR Erythrocyte sedimentation rate, WBC White blood cell, HB Hemoglobin, PLT Platelet, ANA Antinuclear antibodies, RF Rheumatoid factor, IL Interleukin, TNF-a a-tumor necrosis factor, VitD3 Vitamin D3, NK Natural killer cells

Source: Factors associated with lung involvement. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Cross-sectional study.

Cross-sectional study

Examines a population at a particular point in time.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

This cross-sectional study was conducted between January 2019 and June 2021 at the Department of Rheumatology and Immunology, Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University.

Source: Methods.

The patients were treatment-naive and had been diagnosed with rheumatic diseases for the first time.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Lung involvement in children with newly diagnosed rheumatic diseases: characteristics and associations

Cross-sectional study · Pediatric Rheumatology Online Journal · 2022

Original publication title

Lung involvement in children with newly diagnosed rheumatic diseases: characteristics and associations

Hua Huang; Yabin Hu; Yufen Wu; Fei Ding; Xuemei Xu; Yingying Jin; Yanliang Jin; Yixiao Bao

© The Author(s) 2022

Original publication · Publisher record · CC BY 4.0 · CC0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

Pediatric patients with treatment-naive, newly diagnosed rheumatic diseases are prone to pulmonary involvement. Increased ESR and CD4/CD8 are associated with elevated odds of lung involvement in patients. We recommend routine pulmonary evaluation in such patients, especially in high-risk patients, even in the absence of respiratory symptoms, once they are diagnosed with rheumatic disease.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

Pulmonary complications of rheumatic diseases may cause functional impairment and increase mortality. However, reports regarding detection of lung involvement in children with treatment-naive, newly diagnosed rheumatic diseases are scarce. Herein, we aimed to describe the characteristics of such patients and explore the association between lung involvement and rheumatic disease.

Source: Background

Abstract: What methods does the paper describe?

From January 2019 to June 2021, 48 pediatric patients with treatment-naive, newly diagnosed rheumatic diseases at Department of Rheumatology and Immunology, Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University were included with pulmonary function tests (PFTs) and high-resolution computed tomography (HRCT) findings, and 51 age-matched healthy controls were examined based on PFTs. Univariate and multivariable logistic regression analyses were used to investigate the clinical characters and laboratory parameters associated with lung involvement in these patients.

Source: Methods

Abstract: Results

Asymptomatic patients had a faster respiratory rate and a higher ratio of forced expiratory volume in 1 s/forced vital capacity than the controls (P < 0.05). More patients than controls were observed to have a decreased DLCO below the lower limit of normal (18 of 45 [40.0%] vs. 6 of 36, respectively; P = 0.041). Among the 48 patients, 8 (16.7%) had abnormal HRCT findings and 27 (56.3%) had abnormal PFT results. Thirty-one (64.6%) patients had lung involvement.

Logistic regression revealed that increases in the erythrocyte sedimentation rate (ESR) and CD4/CD8 ratio were associated with increased odds ratio of lung involvement (1.037, 95% CI: 1.003 to 1.072; 9.875, 95% CI: 1.296 to 75.243, respectively).

Source: Results

Abstract: Conclusions

Pediatric patients with treatment-naive, newly diagnosed rheumatic diseases are prone to pulmonary involvement. Increased ESR and CD4/CD8 are associated with elevated odds of lung involvement in patients. We recommend routine pulmonary evaluation in such patients, especially in high-risk patients, even in the absence of respiratory symptoms, once they are diagnosed with rheumatic disease.

Source: Conclusions
Authors’ abstract

Background

Pulmonary complications of rheumatic diseases may cause functional impairment and increase mortality. However, reports regarding detection of lung involvement in children with treatment-naive, newly diagnosed rheumatic diseases are scarce. Herein, we aimed to describe the characteristics of such patients and explore the association between lung involvement and rheumatic disease.

Methods

From January 2019 to June 2021, 48 pediatric patients with treatment-naive, newly diagnosed rheumatic diseases at Department of Rheumatology and Immunology, Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University were included with pulmonary function tests (PFTs) and high-resolution computed tomography (HRCT) findings, and 51 age-matched healthy controls were examined based on PFTs. Univariate and multivariable logistic regression analyses were used to investigate the clinical characters and laboratory parameters associated with lung involvement in these patients.

Results

Asymptomatic patients had a faster respiratory rate and a higher ratio of forced expiratory volume in 1 s/forced vital capacity than the controls (P < 0.05). More patients than controls were observed to have a decreased DLCO below the lower limit of normal (18 of 45 [40.0%] vs. 6 of 36, respectively; P = 0.041). Among the 48 patients, 8 (16.7%) had abnormal HRCT findings and 27 (56.3%) had abnormal PFT results. Thirty-one (64.6%) patients had lung involvement.

Logistic regression revealed that increases in the erythrocyte sedimentation rate (ESR) and CD4/CD8 ratio were associated with increased odds ratio of lung involvement (1.037, 95% CI: 1.003 to 1.072; 9.875, 95% CI: 1.296 to 75.243, respectively).

Conclusions

Pediatric patients with treatment-naive, newly diagnosed rheumatic diseases are prone to pulmonary involvement. Increased ESR and CD4/CD8 are associated with elevated odds of lung involvement in patients. We recommend routine pulmonary evaluation in such patients, especially in high-risk patients, even in the absence of respiratory symptoms, once they are diagnosed with rheumatic disease.

Publication and source details

Original title: Lung involvement in children with newly diagnosed rheumatic diseases: characteristics and associations

Hua Huang; Yabin Hu; Yufen Wu; Fei Ding; Xuemei Xu; Yingying Jin; Yanliang Jin; Yixiao Bao

Pediatric Rheumatology Online Journal · 2022

© The Author(s) 2022https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.http://dx.doi.org/10.13039/501100001809National Natural Science Foundation of China81870024Bao Yixiao

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-12T07:51:20.687412+00:00

DOI: 10.1186/s12969-022-00731-5 · PMC9392295